サワイグループホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/11/11 | 4,150 | 4,155 | 4,090 | 4,115 | +50 | +1.2% | 187,800 |
| 2022/11/10 | 4,000 | 4,090 | 3,960 | 4,065 | +50 | +1.2% | 178,100 |
| 2022/11/09 | 4,095 | 4,095 | 3,985 | 4,015 | -200 | -4.7% | 266,100 |
| 2022/11/08 | 4,170 | 4,235 | 4,135 | 4,215 | +85 | +2.1% | 176,700 |
| 2022/11/07 | 4,200 | 4,200 | 4,130 | 4,130 | -15 | -0.4% | 118,300 |
| 2022/11/04 | 4,270 | 4,275 | 4,140 | 4,145 | -175 | -4.1% | 150,600 |
| 2022/11/02 | 4,300 | 4,355 | 4,270 | 4,320 | +45 | +1.1% | 111,600 |
| 2022/11/01 | 4,300 | 4,315 | 4,250 | 4,275 | -10 | -0.2% | 84,100 |
| 2022/10/31 | 4,225 | 4,300 | 4,225 | 4,285 | +60 | +1.4% | 118,900 |
| 2022/10/28 | 4,210 | 4,265 | 4,190 | 4,225 | +30 | +0.7% | 345,800 |
| 2022/10/27 | 4,210 | 4,230 | 4,135 | 4,195 | -15 | -0.4% | 135,200 |
| 2022/10/26 | 4,150 | 4,220 | 4,150 | 4,210 | +100 | +2.4% | 128,900 |
| 2022/10/25 | 4,140 | 4,150 | 4,085 | 4,110 | -50 | -1.2% | 90,700 |
| 2022/10/24 | 4,205 | 4,205 | 4,145 | 4,160 | -5 | -0.1% | 71,800 |
| 2022/10/21 | 4,195 | 4,215 | 4,145 | 4,165 | -65 | -1.5% | 75,100 |
| 2022/10/20 | 4,205 | 4,250 | 4,200 | 4,230 | +5 | +0.1% | 80,900 |
| 2022/10/19 | 4,280 | 4,285 | 4,225 | 4,225 | -40 | -0.9% | 77,000 |
| 2022/10/18 | 4,285 | 4,290 | 4,235 | 4,265 | +40 | +0.9% | 105,300 |
| 2022/10/17 | 4,310 | 4,325 | 4,225 | 4,225 | -110 | -2.5% | 96,600 |
| 2022/10/14 | 4,315 | 4,340 | 4,285 | 4,335 | +130 | +3.1% | 153,200 |
| 2022/10/13 | 4,200 | 4,230 | 4,190 | 4,205 | -10 | -0.2% | 111,100 |
| 2022/10/12 | 4,230 | 4,270 | 4,185 | 4,215 | +30 | +0.7% | 175,900 |
| 2022/10/11 | 4,155 | 4,220 | 4,155 | 4,185 | -70 | -1.6% | 168,200 |
| 2022/10/07 | 4,240 | 4,290 | 4,225 | 4,255 | -35 | -0.8% | 120,900 |
| 2022/10/06 | 4,230 | 4,315 | 4,220 | 4,290 | +80 | +1.9% | 148,200 |
| 2022/10/05 | 4,230 | 4,245 | 4,185 | 4,210 | +15 | +0.4% | 109,000 |
| 2022/10/04 | 4,140 | 4,195 | 4,120 | 4,195 | +105 | +2.6% | 125,700 |
| 2022/10/03 | 4,070 | 4,100 | 4,025 | 4,090 | +30 | +0.7% | 106,200 |
| 2022/09/30 | 4,095 | 4,125 | 4,050 | 4,060 | -25 | -0.6% | 137,100 |
| 2022/09/29 | 4,015 | 4,090 | 4,005 | 4,085 | +50 | +1.2% | 92,500 |
| 2022/09/28 | 3,995 | 4,035 | 3,970 | 4,035 | +10 | +0.2% | 142,400 |
| 2022/09/27 | 4,000 | 4,080 | 4,000 | 4,025 | +25 | +0.6% | 127,900 |
| 2022/09/26 | 3,985 | 4,015 | 3,980 | 4,000 | ±0 | ±0% | 163,100 |
| 2022/09/22 | 4,000 | 4,015 | 3,955 | 4,000 | -40 | -1% | 132,400 |
| 2022/09/21 | 4,020 | 4,045 | 3,970 | 4,040 | -20 | -0.5% | 122,200 |
| 2022/09/20 | 4,030 | 4,060 | 4,005 | 4,060 | +50 | +1.2% | 92,300 |
| 2022/09/16 | 3,980 | 4,040 | 3,980 | 4,010 | -5 | -0.1% | 178,300 |
| 2022/09/15 | 3,990 | 4,020 | 3,965 | 4,015 | +15 | +0.4% | 141,600 |
| 2022/09/14 | 3,990 | 4,020 | 3,970 | 4,000 | -15 | -0.4% | 212,800 |
| 2022/09/13 | 4,000 | 4,070 | 4,000 | 4,015 | -10 | -0.2% | 121,200 |
| 2022/09/12 | 4,060 | 4,060 | 4,000 | 4,025 | +25 | +0.6% | 66,300 |
| 2022/09/09 | 3,990 | 4,035 | 3,975 | 4,000 | +15 | +0.4% | 154,700 |
| 2022/09/08 | 3,965 | 4,000 | 3,965 | 3,985 | +70 | +1.8% | 102,300 |
| 2022/09/07 | 3,885 | 3,920 | 3,855 | 3,915 | -35 | -0.9% | 190,400 |
| 2022/09/06 | 3,985 | 4,005 | 3,935 | 3,950 | -60 | -1.5% | 108,300 |
| 2022/09/05 | 4,030 | 4,050 | 4,005 | 4,010 | -75 | -1.8% | 103,800 |
| 2022/09/02 | 4,060 | 4,095 | 3,990 | 4,085 | +45 | +1.1% | 199,300 |
| 2022/09/01 | 4,085 | 4,140 | 4,035 | 4,040 | -75 | -1.8% | 157,900 |
| 2022/08/31 | 4,120 | 4,140 | 4,065 | 4,115 | -95 | -2.3% | 244,000 |
| 2022/08/30 | 4,175 | 4,240 | 4,150 | 4,210 | +60 | +1.4% | 587,500 |
651～
700
件表示中 / 1045件
類似銘柄と比較する
現在ご覧いただいている「サワイＧＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サワイＧＨＤ | 181,000円 | +5.9% | +684.6% | 3.04% | 12.01倍 | 1.20倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| ツムラ | 351,700円 | +3.8% | -19.9% | 3.87% | 11.42倍 | 0.87倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 日本新薬 | 311,800円 | +8.0% | -15.3% | 3.98% | 8.75倍 | 0.85倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ペプチド | 153,100円 | +5.0% | +1.5% | 0.00% | 13.10倍 | 3.48倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 396,500円 | +3.6% | +6.1% | 3.03% | 13.36倍 | 0.79倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム
